Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1955 1
1957 1
1999 1
2002 1
2003 1
2004 1
2005 3
2006 2
2007 2
2008 2
2009 1
2010 2
2011 3
2012 2
2013 1
2014 1
2016 1
2017 3
2018 3
2019 1
2020 4
2021 8
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.
Friedrich M, Pohin M, Jackson MA, Korsunsky I, Bullers SJ, Rue-Albrecht K, Christoforidou Z, Sathananthan D, Thomas T, Ravindran R, Tandon R, Peres RS, Sharpe H, Wei K, Watts GFM, Mann EH, Geremia A, Attar M; Oxford IBD Cohort Investigators; Roche Fibroblast Network Consortium; McCuaig S, Thomas L, Collantes E, Uhlig HH, Sansom SN, Easton A, Raychaudhuri S, Travis SP, Powrie FM. Friedrich M, et al. Among authors: geremia a. Nat Med. 2021 Nov;27(11):1970-1981. doi: 10.1038/s41591-021-01520-5. Epub 2021 Oct 21. Nat Med. 2021. PMID: 34675383 Free PMC article.
Innate and adaptive immunity in inflammatory bowel disease.
Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Geremia A, et al. Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15. Autoimmun Rev. 2014. PMID: 23774107 Review.
Innate Lymphoid Cells in Intestinal Inflammation.
Geremia A, Arancibia-Cárcamo CV. Geremia A, et al. Front Immunol. 2017 Oct 13;8:1296. doi: 10.3389/fimmu.2017.01296. eCollection 2017. Front Immunol. 2017. PMID: 29081776 Free PMC article. Review.
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.
Kurioka A, Cosgrove C, Simoni Y, van Wilgenburg B, Geremia A, Björkander S, Sverremark-Ekström E, Thurnheer C, Günthard HF, Khanna N; Swiss HIV Cohort Study; Oxford IBD Cohort Investigators; Walker LJ, Arancibia-Cárcamo CV, Newell EW, Willberg CB, Klenerman P. Kurioka A, et al. Among authors: geremia a. Front Immunol. 2018 Apr 9;9:486. doi: 10.3389/fimmu.2018.00486. eCollection 2018. Front Immunol. 2018. PMID: 29686665 Free PMC article.
A Primary-Care Interventional Model on the Diverticular Disease: Searching for the Optimal Therapeutic Schedule.
Campanini A, De Conto U, Cavasin F, Bastiani F, Camarotto A, Gardini L, Geremia A, Marastoni C, Missorini C, Quarantelli E, Sassi U, Scarabello F, Dal Bo N, Riccò M, Grillo S, Landi S, Di Mario F. Campanini A, et al. Among authors: geremia a. J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S93-6. doi: 10.1097/MCG.0000000000000670. J Clin Gastroenterol. 2016. PMID: 27622379
The IL-23/IL-17 pathway in inflammatory bowel disease.
Geremia A, Jewell DP. Geremia A, et al. Expert Rev Gastroenterol Hepatol. 2012 Apr;6(2):223-37. doi: 10.1586/egh.11.107. Expert Rev Gastroenterol Hepatol. 2012. PMID: 22375527 Review.
46 results